Walleye Capital
APEN

Walleye Capital’s Apollo Endosurgery, Inc. APEN Stock Holding History

Walleye Capital’s Portfolio APEN Stock Details APEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-12,187
Closed -$44K – 3668
2022
Q2 		$44K Buy
+12,187
New +$57.6K ﹤0.01% 1837
2022
Q1 		– Sell
-18,014
Closed -$152K – 2758
2021
Q4 		$152K Buy
+18,014
New +$157K ﹤0.01% 1559

Other funds holding APEN

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Walleye Capital's APEN Position: Q3 2022 in Review

Walleye Capital sold out of Apollo Endosurgery, Inc. (APEN) in Q3 2022, closing a stake of 12,187 shares — an estimated $44K sold.

Walleye Capital first reported a position in APEN in Q4 2021 and held it in 2 quarters. The position peaked at $152K in Q4 2021. 53 funds tracked by Wall St. Rank hold APEN as of Q3 2022.

  • Walleye Capital reported no remaining Apollo Endosurgery, Inc. position as of Q3 2022 after selling out during the quarter.
  • Walleye Capital sold 12,187 Apollo Endosurgery, Inc. shares in Q3 2022, an estimated $44K.
  • Walleye Capital first reported a position in Apollo Endosurgery, Inc. in Q4 2021 and held it in 2 quarters.
  • Walleye Capital's Apollo Endosurgery, Inc. position peaked at $152K in Q4 2021.
  • 53 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q3 2022.

Based on Walleye Capital's 13F filing for Q3 2022, filed 14 Nov 2022.